Late Pleistocene woolly mammoths.

Researchers sequenced a 44,800-year-old Siberian woolly mammoth genome and a Wrangel Island mammoth that lived 4,300 year ago, close to the time of extinction.

Though the edit was made in non-viable zygotes, the study wades into human germline engineering, a topic of great consternation for the CRISPR/Cas9 research community.

By sequencing the exomes of breast cancer patients from founder populations, researchers have uncovered a novel breast cancer susceptibility gene.

The algorithm may be able to rationally determine the three-drug strategy with the best chance of overcoming resistance and improving survival in advanced lung cancer patients.

Sequencing on samples from individuals in a previously uncontacted Venezuelan tribe pointed to extraordinarily diverse gut and skin microbiomes.

The company issued more than 8.6 million shares at €11.50 per share in its IPO. Its shares list on Euronext Brussels under ticker symbol "BCART."

The results provide early evidence for the ability of haplotypes in the HLA-DRB1 gene to predict outcome and drug response, which will have to be further replicated.

The results provide early evidence for the ability of haplotypes in the HLA-DRB1 gene to predict outcome and drug response, which will have to be further replicated.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease. 

Grace Bio-Labs has developed the ArrayCAM Microarray System, a complete protein microarray analytical solution comprised of high protein- binding porous nitrocellulose (PNC), multi-color quantum nanocrystal detection labels, rapid image acquisition instrumentation including automated software analysis to overcome typical challenges associated with the precise study of cell signaling pathways such as sensitivity for detection of low abundance proteins and consistent data normalization.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.